Olmesartan/Amlodipine/Hydrochlorothiazide Provides Significantly Better Ambulatory BP Control Than olmesartan/amlodipine in Patients Defined by Gender, Diabetes and Obesity

Trial Profile

Olmesartan/Amlodipine/Hydrochlorothiazide Provides Significantly Better Ambulatory BP Control Than olmesartan/amlodipine in Patients Defined by Gender, Diabetes and Obesity

Completed
Phase of Trial: Phase III

Latest Information Update: 18 May 2012

At a glance

  • Drugs Hydrochlorothiazide; Olmesartan medoxomil/amlodipine
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2012 New trial record
    • 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top